Carcinoembryonic antigen immunoradiometric assay kit RIA

The CEA-RIACT kit is an immunoradiometric assay for the carcinoembryonic antigen (CEA), a major tumor marker.

Download the protocols

The CEA-RIACT kit is an immunoradiometric assay for the carcinoembryonic antigen (CEA), a major tumor marker.

Size

Cat. number selected :

Quantity

In stock

Overview

Determine stage and prognosis of colorectal cancers (significant correlation in the last two stages of the Dukes classification)

Assess therapeutic efficacy (post-surgery, chemotherapy or radiation treatment)

Decide whether to perform early repeat surgery using this indisputable indicator in the diagnosis of recurrences

Assess a patient's response to treatment in breast and lung cancers, in which CEA levels are linked to the metastatic spread of the disease

Confirm diagnosis and monitor relapses of medullary thyroid cancer, using the combination of CEA and thyrocalcitonin

Benefits

ACCURATE AND RELIABLE ASSAY
QUICK AND CONVENIENT

Assay principle: sandwich

Two anti-CEA monoclonal antibodies are used in the sandwich. The first monoclonal antibody is adsorbed onto the tube walls. The second monoclonal antibody, radiolabeled with iodine-125, is used as the tracer. One-step assay procedure: 1h at RT / shaking.